Cabergoline-Related Severe Restrictive Mitral Regurgitation
Authors:
- Antonio PineroAPAntonio Pinero
- Pedro Marcos-AlbercaPMPedro Marcos-Alberca
- Jose FortesJFJose Fortes
- 3 November 2005
- journal article
- letter
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 353 (18) , 1976-1977
Abstract
A 74-year-old man presented with progressive and severe dyspnea of two months' duration. The patient had Parkinson's disease that had initially been treated with levodopa, to which cabergoline had been added during the preceding four months. The physical examination was notable for increased jugular venous pressure, bilateral rales, and edema in both legs. On auscultation, a gallop rhythm and a 2/6 pansystolic murmur radiating to the axilla were noted. A chest radiograph showed mild cardiomegaly and signs of acute pulmonary edema. Electrocardiography demonstrated sinus rhythm at 80 beats per minute with left atrial enlargement. Transthoracic echocardiography revealed severe mitral regurgitation through thickened, retracted mitral leaflets with incomplete coaptation ( Figure 1A , Figure 1B , and Figure 1C ). Since there was no commissural or chordal fusion, a rheumatic cause was unlikely. The excursion of the mitral leaflets was severely impaired. Echocardiography four months earlier had shown no mitral-valve disease. Serum levels of 5-hydroxytryptamine and urinary 5-hydroxyindoleacetic acid were within normal limits.Keywords
This publication has 4 references indexed in Scilit:
- Treatment of Parkinson's disease with pergolide and relation to restrictive valvular heart diseaseThe Lancet, 2004
- Effects of acute prolactin manipulation on sexual drive and function in malesJournal of Endocrinology, 2003
- Valvular Heart Disease Associated with Fenfluramine–PhentermineNew England Journal of Medicine, 1997
- Valve Disease Associated with Ergot Alkaloid Use: Echocardiographic and Pathologic CorrelationsAnnals of Internal Medicine, 1992